Structure-based de novo design of ligands using a three-dimensional model of the insulin receptor
…, L Wei, FP Ottensmeyer, I Goldfine, BA Maddux…
Index: Tan, Christopher; Wei, Lianhu; Ottensmeyer, F. Peter; Goldfine, Ira; Maddux, Betty A.; Yip, Cecil C.; Batey, Robert A.; Kotra, Lakshmi P. Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 6 p. 1407 - 1410
Full Text: HTML
Citation Number: 18
Abstract
For the first time, a three-dimensional model of the insulin receptor is used in the de novo design of novel ligands that potentially mimic interactions of insulin at its receptor. Compound 4 competed with insulin as seen in autophosphorylation assays and inhibited up to 68% of IR autophosphorylation at 300 μM of 4 in 3T3IR cells induced by 1 nM insulin. This model provides a basis for the design of potent insulin receptor ligands.
Related Articles:
Syntheses of phosphonic esters of alendronate, pamidronate and neridronate
[Guenin, Erwann; Monteil, Maelle; Bouchemal, Nadia; Prange, Thierry; Lecouvey, Marc European Journal of Organic Chemistry, 2007 , # 20 p. 3380 - 3391]
[Smits, Rogier A.; Adami, Maristella; Istyastono, Enade P.; Zuiderveld, Obbe P.; Van Dam, Cindy M. E.; De Kanter, Frans J. J.; Jongejan, Aldo; Coruzzi, Gabriella; Leurs, Rob; De Esch, Iwan J. P. Journal of Medicinal Chemistry, 2010 , vol. 53, # 6 p. 2390 - 2400]
Synthesis and characterization of stable N-phthalimidyl-2, 3-butadienoates
[Kathawala, F. G.; Schuster, H. F.; Shapiro, M. J. Tetrahedron Letters, 1981 , vol. 22, # 38 p. 3703 - 3706]